Stay updated with breaking news from Advm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) announced its quarterly earnings data on Tuesday. The biotechnology company reported ($0.35) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.34) by ($0.01), MarketWatch Earnings reports. Shares of NASDAQ ADVM opened at $1.34 on Thursday. Adverum Biotechnologies has a twelve month low of $1.21 and a twelve […]
Equities analysts predict that Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) will announce earnings per share (EPS) of ($0.42) for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Adverum Biotechnologies’ earnings, with the lowest EPS estimate coming in at ($0.43) and the highest estimate coming in at ($0.41). Adverum Biotechnologies […]
Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) shares passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $1.43 and traded as low as $1.40. Adverum Biotechnologies shares last traded at $1.47, with a volume of 856,568 shares trading hands. Separately, Zacks Investment Research […]
/PRNewswire/ -- dvm360®, the No. 1 multimedia platform in the animal health industry, is accepting entries for best-in-class architectural design recognition...
According to the Bureau of Labor Statistics, veterinary jobs are expected to grow 17% from 2020 to 2030.